Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CRL · against 126 other Healthcare companies of similar size
Ranked #112 of 127 · scores higher than 12% of peers · safety percentile 14
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)20 peers with a safety percentile of 10–19, including CRL · Click a bar to see the companies
Mainly because of its beta, debt / equity and current ratio, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | CRL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 119 reported | 1.05× | 0.34× | 12% | 33% | |
| BetaLower is better · 126 reported | 1.34 | 0.68 | 12% | 33% | |
| Current ratioHigher is better · 121 reported | 1.35× | 2.14× | 23% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 10.1B EUR (≈$11.1B) | 99 | ||
| 2 | 9.0B USD | 98 | 51 | |
| 3 | 10.2B USD | 97 | ||
| 4 | 9.8B USD | 96 | ||
| 5 | 8.8B USD | 94 | 50 | |
| 108 | 14.9B EUR (≈$16.4B) | 17 | 52 | |
| 109 | 8.7B USD | 16 | 26 | |
| 110 | 9.3B USD | 15 | 64 | |
| 111 | 13.2B USD | 14 | 30 | |
| 112 | 16.9B USD | 14 | 37 | |
| 113 | 15.8B EUR (≈$17.4B) | 13 | 47 | |
| 114 | 73.2B SAR (≈$19.8B) | 13 | 56 | |
| 115 | 111.7B DKK (≈$16.8B) | 12 | 53 | |
| 116 | 21.4B USD | 12 | 67 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score